Amir Fathi, MD

https://www.massgeneral.org/doctors/18613/amir-fathi

Articles by Amir Fathi, MD

Amir Fathi, MD, Massachusetts General Hospital

Why Education and Collaboration Are Key to Bispecific Therapy Administration: Amir Fathi, MD

October 13th 2025

Experts discuss the importance of initiating blinatumomab treatment for acute lymphoid leukemia in academic centers for optimal patient care.

Considerations for Patient Monitoring Following CAR T and Bispecific Administration: Amir Fathi, MD

ByMaggie L. Shaw,Amir Fathi, MD

August 14th 2025

Amir Fathi, MD, leukemia specialist at Massachusetts General Hospital, discusses the importance of advocacy by both patients and their treatment team and key distinct toxicities that require vigilance.

Expertise Is Essential to Bispecific Access for Patients With Acute Leukemias: Amir Fathi, MD

ByMaggie L. Shaw,Amir Fathi, MD

July 23rd 2025

Amir Fathi, MD, discusses one of the biggest nonfinancial barriers to bispecific therapies: the expertise required to safely administer and manage them.

Amir Fathi, MD

Articles by Amir Fathi, MD

Why Education and Collaboration Are Key to Bispecific Therapy Administration: Amir Fathi, MD

Considerations for Patient Monitoring Following CAR T and Bispecific Administration: Amir Fathi, MD

Expertise Is Essential to Bispecific Access for Patients With Acute Leukemias: Amir Fathi, MD

Latest Updated Articles

Trending on AJMC

Ongoing COVID-19 Circulation Linked to Increases in Health-Related Work Absences, Workforce Exits

After Narrow Miss in Phase 3 Study, IO Biotech Ponders Next Steps for Immune-Modulatory, Off-the-Shelf Cancer Vaccine

Guidelines for Bronchiectasis Highlight Multiple Treatment Methods

Many US Health Care Workers Face Poverty, Food Insecurity, and Housing Instability

Combination Therapy Proves More Effective in NSCLC Compared With Chemotherapy